Product Pipline Avirmax Biopharma Inc. is at preclinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development. Program Indication Lead Design & Production AAV - Vector Biochemical Potency Preclinical IND - Enabling Phase 1 Commercial Rights Milestone iCare CNV wAMD, DME, PCV ABI-110 0% ABI-112 0% IND 2H23 GA ABI-201 0% iCare GA dAMD ABI-210 0% dAMD ABI-220 0% iCare NIU NIU, uvCNV, UMO ABI-107 , ABI-108 0% iCare RGC Glaucoma ABI-902 0% PIND 2H23 AMD = Age-Related Macular DegenerationDME = Diabetic Macular EdemaCNV = Choroidal Neovascularization PCV = Polypoidal Choroidal VasculopathyRVO= Retinal Vein Occlusion GA = Geographic atrophy